Comparison of the Effect of Two Interventions on Liver Frailty Index in Pre-frail and Frail Cirrhotic Patients Enlisted for Liver Transplantation
NCT06149026 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2023-11-28
Summary
The goal of this prospective, double blind randomized clinical trial is to compare the effectiveness of two interventions in improve frailty (measured by Liver Frailty Index) and quality of life (measured by Chronic Liver Disease Questionnaire - CLDQ) in listed patients with cirrhosis.
The main questions it aims to answer are:
* if the intervention group (physical and nutritional therapy) could improve LFI over control group (physical and nutritional counseling).
* if the intervention group could improve secondary outcomes as CLDQ, hand grip and gait velocity.
Participants will be evaluated in a registry of basal variables such as demographic factors, weight, height and brachial circumference, comorbidities, MELD and MELD-Na, Child Pugh classification, general blood exams, etiology of cirrhosis, presence of hepatocellular carcinoma, ascites, or hepatic encephalopathy and their basal LFI, gait velocity, hand grip and CLDQ. The participants will be randomized in an intervention group or in a control group at the same time of their first evaluation and will receive the group instructions depending on what group the participants belong, and will be evaluated at 4 weeks, 8 weeks, and 12 weeks with applying LFI, measuring of gait velocity, hand grip and a nutritional survey with the intake in the last 24 hours. Finally, researchers will compare interventional group with control group if the first group could improve frailty, measured by Liver Frailty Index and the secondary outcomes with the nutritional and physical therapy.
Conditions
- Cirrhosis, Liver
Interventions
- OTHER
-
Physical and nutritional therapy
The patients will be evaluated and followed by a nutritionist and a physical therapist for 12 weeks. In that time, the patients will receive workouts according to their evaluations and a specific nutritional guide according to the nutritionist's evaluations.
Sponsors & Collaborators
-
Pontificia Universidad Catolica de Chile
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-01
- Primary Completion
- 2023-12-01
- Completion
- 2023-12-01
Countries
- Chile
Study Locations
More Related Trials
-
Transitional Care Interventions for Patients With Cirrhosis Post-TIPS
NCT02877953 ·Status: UNKNOWN ·Phase: NA
-
Frailty in Patients With Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of Multifactorial Intervention
NCT04243148 ·Status: COMPLETED ·Phase: NA
-
Enteral Nutrition in Liver Cirrhosis
NCT00168961 ·Status: COMPLETED ·Phase: PHASE4
-
Transitional Care Program for Fluid Overload in Cirrhosis
NCT06174272 ·Status: RECRUITING ·Phase: NA
-
Health IT Generated PROs to Improve Outcomes in Cirrhosis
NCT03564626 ·Status: COMPLETED ·Phase: NA
-
Liver Transplantation Versus Alternative Therapies for Patients With Pugh B Alcoholic Cirrhosis
NCT00701792 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation in Decompensated Cirrhosis
NCT04842539 ·Status: COMPLETED ·Phase: NA
-
Acute-On-Chronic Liver Failure In Cirrhotic Patients
NCT04790435 ·Status: COMPLETED
-
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
NCT06136221 ·Status: RECRUITING ·Phase: NA
-
Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic Patients
NCT02427906 ·Status: UNKNOWN
-
Portal Vein Thrombosis in Cirrhosis
NCT02275585 ·Status: WITHDRAWN
-
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
NCT06855056 ·Status: RECRUITING
-
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
NCT07172035 ·Status: RECRUITING
-
Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study
NCT06948565 ·Status: RECRUITING
-
Telehealth Intervention in Cirrhotics
NCT03969186 ·Status: COMPLETED ·Phase: NA
-
Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care
NCT04178096 ·Status: COMPLETED ·Phase: NA
-
Phase Angle and Mortality in Patients With Cirrhosis
NCT02023177 ·Status: COMPLETED
-
Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
NCT02335580 ·Status: COMPLETED
-
Effect of Exercise on Liver Cirrhosis
NCT05612334 ·Status: COMPLETED ·Phase: NA
-
Feasibility of an App-based Nutrition & Exercise Program in Cirrhosis
NCT05033327 ·Status: COMPLETED ·Phase: NA
-
Methods for Nutritional Assessment in Cirrhosis
NCT02926261 ·Status: UNKNOWN
-
Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics
NCT02923336 ·Status: UNKNOWN ·Phase: NA
-
Precision Medicine to Predict the Trajectory of Liver Cirrhosis: Prospective Cohort Study
NCT05899309 ·Status: UNKNOWN
-
Stem Cell Transplantation in Cirrhotic Patients
NCT02943889 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study
NCT03092401 ·Status: UNKNOWN